Atlas Trials

A Study of Combination Therapy in Patients With Resectable Liver Cancer

Clinical trial NCT07684040 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07684040
Sponsor
Affiliated Hospital of Guangdong Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer (Primary and Metastatic)
Start date
2026-08-01
Primary completion
2030-07-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.